Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesHeight and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial
British Journal of Cancer, 07/02/09
Ahn J et al. - In a study to determine the association between height and risk of prostate cancer (PCa), results suggest that tallness is associated with increased risk for younger onset, aggressive PCa.
Methods- The association of height with PCa was prospectively examined among 34,268 men.
- Anthropometry was assessed at baseline and 2144 incident PCa cases were identified up to 8.9 yrs of follow-up.
- Tallness was not associated with risk of PCa or with risk of non-aggressive disease, but risk for aggressive PCa tended to be greater in taller men.
- This association was largely limited to men below the age of 65 yrs, although the number of cases was small and risk estimates were somewhat unstable.
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Sponsor
Article Search
Sponsor
Sponsor